| Term 
 
        | Opioid Agonist-Antagonist characteristics: |  | Definition 
 
        | 
Bind to Mu receptor 
producing a limited response (partial agonist)or no response (competitive antagonist)Bind to K and D receptors 
produce agonist effectsproduct antagonist effectsAntagonist properties may attenuate subsequent administration of opioid agonistsSide effects are similar to those of opioid agonistproduce analgesia with limited depression of ventilation and low potential of physical dependence.  |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
chemically related to oxymorphine and naloxoneanalgesic potency equal to morphinemetabolized in the liverquick onset of actionduration of action 3-6hrs |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
reversal of opioid-induced respiratory depression while maintaining some analgesiaReversal of opioid-induced pruritisDose: 5mg IV increments   |  | 
        |  | 
        
        | Term 
 
        | Butorphanol (Stadol) characteristics: |  | Definition 
 
        | 
Low affinity for mu receptorsmoderate affinity for kappa receptors3-4 times more potent than morphine |  | 
        |  | 
        
        | Term 
 
        | Butorphanol (Stadol) uses/dose: |  | Definition 
 
        | Dose: 0.5-2mg IV every 2-4hrs Quick onset of action Duration of Action: 4hrs 
Early Stages of labor pain
Not for pain associated with surgery
Nasal spray indicated for hte management of migraine headaches. |  | 
        |  | 
        
        | Term 
 
        | Butorphanol side effects: |  | Definition 
 
        | 
increased BP, Pulmonary BP and CODepression of ventilation similar to morphineIt may be difficult to achieve good analgesia with opioid agonists in the presence of butorphanolmay cause dysphoric reactionsthese drugs have a ceiling effect such that increasing the doses do not produce additional responses.   |  | 
        |  | 
        
        | Term 
 
        | Pentazocine characteristics: |  | Definition 
 
        | 
agonist effect at D and K receptors
extensive first pass metabolism with only 20% of oral dose entering the metabolism
elimination half-time 2-3hrs Side effects: 
  
Dysphoria including fear of impending death is associated with high doses
Increase in plasma catecholamines causing increased HR, SBP, Pulm. ABP, and left vent. EDP.
Crosses the placenta and may cause fetal depression.   |  | 
        |  | 
        
        | Term 
 
        | Buprenorphine characteristics: |  | Definition 
 
        | Onset: 30min Duration of action: at least 8hrs 
Effective in relieving moderate to severe pain in the post-op period and pain associated with cancer, renal colic, and MI.
Highly lipid soluble
Side effects: Pulonary edema, can precipitate withdrawal    |  | 
        |  |